Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

Another Crack Shows Up In EU Logjam Over GMOs

Dec. 8, 2004

By Peter O'Donnell

EMEA Wants New Guidelines On Carcinogenicity For HIV Drugs

Nov. 24, 2004

By Peter O'Donnell

EMEA Wants New Guidelines On Carcinogenicity For HIV Drugs

Nov. 24, 2004

By Peter O'Donnell

EU Re-Awakening Wanted For Biotechnology Industry

Nov. 10, 2004

By Peter O'Donnell

EU Re-Awakening Wanted For Biotechnology Industry

Nov. 10, 2004

By Peter O'Donnell

New EU Chiefs Promise Hope For Pharmaceutical Industry

Sep. 29, 2004

By Peter O'Donnell

EU Medicines Guidelines Up For General Comment

Sep. 22, 2004

By Peter O'Donnell

EU Medicines Guidelines Up For General Comment

Sep. 22, 2004

By Peter O'Donnell

Biotechnology Industry Laments EU Indecision On GM Thresholds

Sep. 15, 2004

By Peter O'Donnell

Biotechnology Industry Laments EU Indecision On GM Thresholds

Sep. 15, 2004

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...